Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

IPTC NewsCodes: 20000468

Prescription Drugs

Starting from the bottom 300 billion to increase the needle market: leading companies earn 10 billion a year, and some families spend 480,000 a year – yqqlm

  • Post date May 17, 2022 — 01:44 Post Lock Login to View

Read More

Starting from the bottom 300 billion to increase the needle market: leading companies earn 10 billion a year and families spend 480,000 a year

  • Post date May 16, 2022 — 21:32 Post Lock Login to View

Read More

Panlong Pharmaceutical (002864): The subsidiary invested in the establishment of a holding subsidiary company and completed the industrial and commercial registration CFi.CN Zhongcai Network

  • Post date May 15, 2022 — 17:46 Post Lock Login to View

Read More

Tai Chi Group: 2022 Lightweight Main Business Growth Expected_Stock Live_Market Gold Online

  • Post date May 14, 2022 — 11:09 Post Lock Login to View

Read More

Tai Chi Group: The main business growth can be expected in 2022

  • Post date May 14, 2022 — 10:25 Post Lock Login to View

Read More

Tai Chi Group: The main business growth can be expected in 2022

  • Post date May 14, 2022 — 10:25 Post Lock Login to View

Read More

Yuanxin Technology opens up online and offline out-of-hospital management paths to serve chronic disease patients

  • Post date May 13, 2022 — 13:21 Post Lock Login to View

Read More

China Resources' acquisition of Kunyao's comprehensive centralized procurement accelerates the integration of the traditional Chinese medicine industry

  • Post date May 11, 2022 — 03:43 Post Lock Login to View

Read More

Kunming Pharmaceutical Group plans to expand its listing platform to 17 by "adding Ding" to China Resources, the leader of Panax notoginseng

  • Post date May 10, 2022 — 08:12 Post Lock Login to View

Read More

Kunpharm Group plans to change its ownership by 2.9 billion, and China Resources, the leader of Panax notoginseng, will expand its listing platform to 17 Kunpharm Group.

  • Post date May 10, 2022 — 08:05 Post Lock Login to View

Read More

China Resources Pharmaceutical (03320): China Resources Sanjiu (000999.SZ) plans to increase its holdings of Kunpharm Group (600422.SH) by about 212 million shares for 2.902 billion yuan_ Oriental Fortune Net

  • Post date May 10, 2022 — 07:55 Post Lock Login to View

Read More

China Resources 392.9 billion won the controlling stake of Kunming Pharmaceutical Group

  • Post date May 10, 2022 — 00:12 Post Lock Login to View

Read More

China Resources 392.9 billion won the controlling stake of Kunming Pharmaceutical Group

  • Post date May 10, 2022 — 00:04 Post Lock Login to View

Read More

"Huali Department" exit: China Resources Sanjiu plans to take charge of Kunming Pharmaceutical Group with 2.902 billion yuan before the suspension of trading. Kunming Pharmaceutical Group

  • Post date May 9, 2022 — 22:22 Post Lock Login to View

Read More

Industry Observation Chain Pharmacy: Q1 business recovery is better than previously expected inflection point to see Q2 same store growth_Securities News_Finance Gold Online

  • Post date May 9, 2022 — 12:09 Post Lock Login to View

Read More

China Resources Sanjiu was surveyed by one institution: the company will raise the price of some varieties moderately from time to time, such as Ganmaoling, which will have a small price increase in recent years (with survey questions and answers)

  • Post date May 9, 2022 — 10:51 Post Lock Login to View

Read More

The "marriage" of the two major traditional Chinese medicine companies, China Resources Sanjiu plans to "eat" Kunyao Group's injection medicine for 2.9 billion yuan jqknews

  • Post date May 9, 2022 — 00:24 Post Lock Login to View

Read More

The "marriage" of the two major traditional Chinese medicine companies, China Resources Sanjiu plans to "eat" Kunming Pharmaceutical Group with 2.9 billion yuan

  • Post date May 9, 2022 — 00:21 Post Lock Login to View

Read More

The "marriage" of the two major traditional Chinese medicine companies: China Resources Sanjiu plans to "eat" Kunming Pharmaceutical Group China Resources Sanjiu with 2.9 billion yuan Teller Report

  • Post date May 8, 2022 — 23:55 Post Lock Login to View

Read More

The "marriage" of the two major traditional Chinese medicine companies, China Resources Sanjiu plans to "eat" Kunming Pharmaceutical Group with 2.9 billion yuan_Shenzhen Hotline

  • Post date May 8, 2022 — 23:54 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.